Clinical Analysis of Pulmonary Thromboembolism and Lung Cancer in 65 Patients
YAN Jing-xia,LIU Jin-ming,GONG Su-gang,CHENG Ke-bin,ZHU Ren
DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2012.015.006
2012-01-01
Abstract:Objective To explore the clinical features of pulmonary thromboembolism (PTE) and lung cancer in 65 patients,in order to improve the recognition,diagnosis and treatment of the diseases.Methods The clinical data were retrospectively reviewed for 596 patients with PTE (65 of them with PTE and lung cancer) from January 2002 to December 2011 in Tongji University affiliated to Shanghai Pulmonary Hospital.The associated clinical factors included age,sex,pathological types of lung cancer,stage of disease,body mass index (BMI),platelet counts of pretherapy,D-dimer,interleukin-1 (IL-1)and tumor necrosis factor (TNF).Results In 596 PTE patients,65 patients (10.91％) were confirmed with lung cancer.Dyspnea (76.92 ％ ) was the most common symptom,then were cough (41.54 ％ ),chest pain (29.23 ％ ).The common signs were respiratory frequency (69.23％ ),fever (67.69％),tachycardia (61.54％).In the 65 patients,there were 24 patients (36.92％) with deep venous thrombosis (DVT) of lower limbs,the symptoms were edema of lower limbs and tenderness.On the pathological types of lung cancer,41 cases (63.08％) were adenocarcinoma.On the stage of lung cancer,58 patients (89.23％) were stage Ⅲ b～ Ⅳ.In PTE and lung cancer patients,cases with high value of platelet counts of pretherapy,IL-1 and TNF were 66.15％,63.08％,36.92％.In non-lung cancer PTE patients,cases with high value of platelet counts of pretherapy,IL-1 and TNF were 36.91％,19.21％,21.65％.There was significant difference between them ( P ＜0.01).58 lung cancer and PTE patients were treated with thrombolysis and (or) anticoagulation,excellence was 13 cases (22.41％),effectiveness was 31 cases (53.45％),inefficiency was 11 cases (18.97％),death was three cases (5.17％).Conclusions Lung cancer is one of the common causes of PTE,usually with DVT at the same time.In the lung cancer and PTE patients,there is no special clinical manifestation.Adenocarcinoma is the most common pathological type,and stage Ⅲ b～ Ⅳ is the most common.During the diagnosis and therapy of lung cancer patients,attention should be paid to the occurrence of PTE.For the PTE patients with unclear cause,high value of platelet counts of pretherapy,IL-1 and TNF are cues of the malignant tumor.For the lung cancer and PTE patients confirmed,thrombolysis and (or) anticoagulation remain the basic therapy.